'Neutropenic patients' diaporamas de présentation

Antibiotic prophylaxis during neutropenia

Antibiotic prophylaxis during neutropenia. New evidence Implications for practice. Anat Gafter-Gvili, Abigail Fraser, Mical Paul Leonard Leibovici Rabin Medical Center, Beilinson Campus. 2002 IDSA guidelines.

878 views • 56 slides

ANTIFUNGAL THERAPY IN FEBRILE NEUTROPENIC PATIENTS REVIEW OF TREATMENT CHOICES AND STRATEGIES

ANTIFUNGAL THERAPY IN FEBRILE NEUTROPENIC PATIENTS REVIEW OF TREATMENT CHOICES AND STRATEGIES. Jean KLASTERSKY, M.D. , Ph. D. Institut Jules Bordet, Brussels, Belgium. G.S. MARTIN et al., NEJM 2003. Mc Neil M, CID 2001;13:;641-647.

877 views • 56 slides

IDSA GUIDELINE 2011

414 views • 41 slides

IDSA GUIDELINE 2011

430 views • 41 slides

Infections in cancer patients

Infections in cancer patients. By Alfred Elias Namour ; M.D. NCI, Cairo University. Objectives. To know the risk factors that predispose cancer patients to infection. To highlight different preventive measures that could be used in cancer patients.

445 views • 34 slides

Immunocompromised Host: LABORATORY APPROACH

525 views • 32 slides

Caspofungin

Caspofungin. Breakthrough Treatment in the Management of Patients with Invasive Candidiasis. Overview: Growing Threat. Serious fungal infections are on the rise Invasive Candida infections 4th most common nosocomial bloodstream infection in the United States*.

600 views • 31 slides

Caspofungin

Caspofungin. Breakthrough Treatment in the Management of Patients with Invasive Candidiasis. Overview: Growing Threat. Serious fungal infections are on the rise Invasive Candida infections 4th most common nosocomial bloodstream infection in the United States*.

358 views • 31 slides

Nosocomial Fungal Infections and Risk Factors in Intensive Care Unit

318 views • 14 slides